Yervoy® Postmarketing Surveillance for Patients in Japan With Unresectable, Malignant Melanoma
Clinical trial NCT02717364 · COMPLETED
Trial details
- NCT number
- NCT02717364
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-08-27
- Primary completion
- 2018-03-07
- Enrollment
- 556
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.